Is dasatinib + querceptin approved to treat any indications unity is studying / is their clinical data? If not then would be hard for them to compete with an a

Is dasatinib + querceptin approved to treat any indications unity is studying / is their clinical data? If not then would be hard for them to compete with an approved drug unless they have some really great clinical data. Also if unity is less toxic that might be better than marginally better effectiveness in the chronic indications they're pursuing Not familiar with Oisin, what is their vector? Does it enable repeat dosing?